What It Is

GHK-Cu, also known as Copper Tripeptide-1, is a naturally occurring peptide that plays a role in rejuvenation and healing processes within the body. It is widely researched for its ability to stimulate collagen production, promote wound healing, and support tissue regeneration.

Its mechanism involves binding copper ions and delivering them to cells where they are needed for key biological functions. GHK-Cu is thought to regulate gene expression related to tissue repair, anti-inflammatory responses, and cellular growth — encouraging synthesis of collagen and glycosaminoglycans that strengthen the extracellular matrix and support skin elasticity.

Who May Benefit

• Skin repair and appearance research
• Wound-healing research
• Recovery from injury involving skin or soft tissue
• Signs-of-aging research
• Tissue-regeneration protocols
• Inflammation-related skin research

What to Expect

GHK-Cu is generally researched over a defined cycle (commonly 6–8 weeks) rather than expected to produce an immediate effect.

Because it works partly through modulating immune response, oxidative stress, and inflammation alongside collagen synthesis, it is often paired with other recovery-focused compounds for a broader tissue-support approach.

What to Pair It With

Reconstitution

Suggested Research Dosing Strategy

Administration Notes

Inject in a fasted state, in the evening, when most healing activity is thought to occur.

Injections with GHK-Cu commonly sting; using “no-sting” reconstitution water can reduce this.

Maintain sterile handling and consistent timing across the research cycle.

Research Considerations

GHK-Cu’s research profile spans cosmetic, dermatological, and general wound-healing contexts, making it one of the more clinically discussed peptides on this list.

As with other compounds here, most protocol-level dosing guidance comes from community and practitioner sources rather than large controlled human trials — treat specific numbers as a starting framework, not an established standard.